News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
The Opportunities Are Endless: Enrique Soto Pérez de Celis signs key international agreement
Enrique Soto/X
Dec 21, 2024, 05:50

The Opportunities Are Endless: Enrique Soto Pérez de Celis signs key international agreement

CU Cancer Center shared a post on X:

“CU Cancer Center’s Associate Director for Global Oncology, Enrique Soto Pérez de Celis, returned from Mexico, where he signed the first of what he hopes will be many partnership agreements with cancer centers in Latin America.

For more details click here.”

The Opportunities Are Endless: Enrique Soto Pérez de Celis signs key international agreement

cancer CU Cancer Center Enrique Soto Perez de Celis OncoDaily Oncology
Special Coverage
Science
Feb 27, 2025, 17:56
Jasmine Kamboj: We need realistic and sustainable expectations of oncologists
Blog
Feb 27, 2025, 17:55
Jean Bustamante Alvarez: I’m starting a new position at Jacobi Medical Center
Blog
Feb 27, 2025, 17:54
European Cancer Summit 2024 Report is out - European Cancer Organisation
Blog
Feb 27, 2025, 17:53
Sahar Mansour: A Proud Moment for Interventional Radiology in Egypt
Blog
Feb 27, 2025, 17:49
C. Ola Landgren: Register now for the annual Miami Myeloma MRD Meeting
Blog
Feb 27, 2025, 17:46
Estela Rodriguez: Nominate yourself or a colleague for an IASLC committee
Science
Feb 27, 2025, 17:42
Loay Kassem: Breast saving surgery without radiotherapy could be the new standard for EBC
Blog
Feb 27, 2025, 17:16
Ruzanna Papyan: Exclusive Educational Session on Immune Landscape of Neuroblastoma
Blog
Feb 27, 2025, 17:13
Submission deadline is approaching for the late-breaker abstracts for MASCC25
Blog
Feb 27, 2025, 17:10
Fertility Preservation Is Key in Survivorship - Childhood Cancer International
Blog
Feb 27, 2025, 17:01
Chris Boshoff: Pfizer has entered into a clinical trial collaboration with Summit Therapeutics
Blog
Feb 27, 2025, 16:55
Daniel De Carvalho: Chronic viral mimicry after p53 loss enables immune evasion in early ovarian cancer